Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Polymorphisms in the promoter regions of MMP-2, MMP-3, MMP-9 and MMP-12 genes as determinants of aneurysmal coronary artery disease.

Lamblin N, Bauters C, Hermant X, Lablanche JM, Helbecque N, Amouyel P.

J Am Coll Cardiol. 2002 Jul 3;40(1):43-8.

2.

Variations in matrix metalloproteinase-1, -3, and -9 genes and the risk of acute coronary syndrome and coronary artery disease in the Chinese Han population.

Xu X, Wang L, Xu C, Zhang P, Yong F, Liu H, Wang J, Shi Y.

Coron Artery Dis. 2013 Jun;24(4):259-65. doi: 10.1097/MCA.0b013e32835ea3af.

PMID:
23377317
3.
4.

Serum matrix metalloproteinase-3 concentration is influenced by MMP-3 -1612 5A/6A promoter genotype and associated with myocardial infarction.

Samnegård A, Silveira A, Lundman P, Boquist S, Odeberg J, Hulthe J, McPheat W, Tornvall P, Bergstrand L, Ericsson CG, Hamsten A, Eriksson P.

J Intern Med. 2005 Nov;258(5):411-9.

5.

[Association between single nucleotide polymorphisms of matrix metalloproteinase-3 gene and the severity of coronary atherosclerosis in patients with coronary artery disease].

Wu NQ, Song L, Hua YH, Lu XF, Ye J, Li JX, Gu DF, Yang YJ.

Zhonghua Xin Xue Guan Bing Za Zhi. 2008 Jun;36(6):501-5. Chinese.

PMID:
19100060
6.

Influences of matrix metalloproteinase-3 gene variation on extent of coronary atherosclerosis and risk of myocardial infarction.

Beyzade S, Zhang S, Wong YK, Day IN, Eriksson P, Ye S.

J Am Coll Cardiol. 2003 Jun 18;41(12):2130-7.

7.

Matrix metalloproteinases in premature coronary atherosclerosis: influence of inhibitors, inflammation, and genetic polymorphisms.

Nanni S, Melandri G, Hanemaaijer R, Cervi V, Tomasi L, Altimari A, Van Lent N, Tricoci P, Bacchi L, Branzi A.

Transl Res. 2007 Mar;149(3):137-44.

PMID:
17320799
8.

Polymorphisms of genes involved in extracellular matrix remodeling and abdominal aortic aneurysm.

Saracini C, Bolli P, Sticchi E, Pratesi G, Pulli R, Sofi F, Pratesi C, Gensini GF, Abbate R, Giusti B.

J Vasc Surg. 2012 Jan;55(1):171-179.e2. doi: 10.1016/j.jvs.2011.07.051. Epub 2011 Nov 16.

10.

Genotype-phenotype association of matrix metalloproteinase-3 polymorphism and its synergistic effect with smoking on the occurrence of acute coronary syndrome.

Liu PY, Li YH, Chan SH, Lin LJ, Wu HL, Shi GY, Chen JH.

Am J Cardiol. 2006 Oct 15;98(8):1012-7. Epub 2006 Aug 22.

PMID:
17027562
11.

Polymorphisms in matrix metalloproteinase-1, -3, -9, and -12 genes in relation to subarachnoid hemorrhage.

Zhang B, Dhillon S, Geary I, Howell WM, Iannotti F, Day IN, Ye S.

Stroke. 2001 Sep;32(9):2198-202.

PMID:
11546917
12.

Matrix metalloproteinases 1, 2, 3 and 9 functional single-nucleotide polymorphisms in idiopathic recurrent spontaneous abortion.

Pereza N, Ostojić S, Volk M, Kapović M, Peterlin B.

Reprod Biomed Online. 2012 May;24(5):567-75. doi: 10.1016/j.rbmo.2012.01.008. Epub 2012 Jan 24.

PMID:
22406112
13.

[Association of matrix metalloproteinase-3 serum level and the promoter 5A/6A polymorphism of the MMP-3 gene with atherosclerotic cerebral infarction].

Huang X, Zhu M, Jin X, Zhang D, Wang L, Ye Z.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2008 Dec;25(6):653-6. Chinese.

PMID:
19065524
14.

Collagenase-1 (-1607 1G/2G), Gelatinase-A (-1306 C/T), Stromelysin-1 (-1171 5A/6A) functional promoter polymorphisms in risk prediction of type 2 diabetic nephropathy.

Gantala SR, Kondapalli MS, Kummari R, Padala C, Tupurani MA, Kupsal K, Galimudi RK, Gundapaneni KK, Puranam K, Shyamala N, Guditi S, Rapur R, Hanumanth SR.

Gene. 2018 Oct 5;673:22-31. doi: 10.1016/j.gene.2018.06.007. Epub 2018 Jun 5.

PMID:
29883760
15.

[Correlations of polymorphisms in matrix metalloproteinase-3 and -7 promoters to susceptibility to brain astrocytoma].

Lu ZQ, Wang YM, Cao YY, Zhang QJ, Zhang XH, Li YH, Wang HS, Xie HL, Jiao BH, Zhang JH.

Ai Zheng. 2007 May;26(5):463-8. Chinese.

PMID:
17672933
16.

Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma.

Hirata H, Okayama N, Naito K, Inoue R, Yoshihiro S, Matsuyama H, Suehiro Y, Hamanaka Y, Hinoda Y.

Carcinogenesis. 2004 Dec;25(12):2379-84. Epub 2004 Aug 19.

PMID:
15319295
17.

Association of Matrix Metalloproteinase-1 and Matrix Metalloproteinase-3 Gene Variants with Ischemic Stroke and Its Subtype.

Huang XY, Han LY, Huang XD, Guan CH, Mao XL, Ye ZS.

J Stroke Cerebrovasc Dis. 2017 Feb;26(2):368-375. doi: 10.1016/j.jstrokecerebrovasdis.2016.09.034. Epub 2016 Oct 25.

PMID:
27793533
18.

Matrix metalloproteinase-3 gene polymorphism (rs3025058) affects markers atherosclerosis in type 2 diabetes mellitus.

Pleskovič A, Letonja MŠ, Vujkovac AC, Starčević JN, Caprnda M, Curilla E, Mozos I, Kruzliak P, Prosecky R, Petrovič D.

Vasa. 2017 Aug;46(5):363-369. doi: 10.1024/0301-1526/a000637. Epub 2017 May 19.

19.

Influence of genetic polymorphism in matrix metalloproteinase-3 on extent of coronary atherosclerosis and risk of coronary artery stenosis.

Seifi M, Fallah S, Firoozrai M.

Arch Med Res. 2009 Oct;40(7):600-4. doi: 10.1016/j.arcmed.2009.08.008.

PMID:
20082876
20.

Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with carotid artery stenosis.

Ghilardi G, Biondi ML, DeMonti M, Turri O, Guagnellini E, Scorza R.

Stroke. 2002 Oct;33(10):2408-12.

PMID:
12364729

Supplemental Content

Support Center